Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
460.42
+0.14 (0.03%)
At close: Nov 6, 2026, 4:00 PM EST
459.47
-0.95 (-0.21%)
After-hours: Nov 6, 2026, 7:59 PM EST
Amgen Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 38,903 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
Revenue Growth | 8.15% | 9.95% | 18.57% | 7.09% | 1.32% | 2.18% |
Gross Profit Gross Profit Growth | 28,191 | 26,014 | 22,966 | 20,395 | 19,947 | 19,525 |
Operating Income Operating Income Growth | 13,274 | 11,574 | 9,676 | 9,823 | 10,098 | 9,151 |
Net Income Net Income Growth | 9,391 | 7,711 | 4,090 | 6,717 | 6,552 | 5,893 |
Earnings Per Share EPS Growth | 17.26 | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 |
EPS Growth | 33.45% | 88.23% | -39.47% | 3.14% | 17.80% | -16.49% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Prolia Prolia Growth | 3,172 | 4,414 | 4,374 | 4,048 | 3,628 | 3,248 |
ENBREL ENBREL Growth | 2,043 | 2,226 | 3,316 | 3,697 | 4,117 | 4,465 |
XGEVA XGEVA Growth | 1,498 | 2,084 | 2,225 | 2,112 | 2,014 | 2,018 |
Repatha Repatha Growth | 3,784 | 3,016 | 2,222 | 1,635 | 1,296 | 1,117 |
Otezla Otezla Growth | 2,028 | 2,265 | 2,126 | 2,188 | 2,288 | 2,249 |
TEPEZZA TEPEZZA Growth | 2,049 | 1,903 | 1,851 | 448 | - | - |
EVENITY EVENITY Growth | 2,626 | 2,100 | 1,563 | 1,160 | 787 | 530 |
KYPROLIS KYPROLIS Growth | 1,325 | 1,412 | 1,503 | 1,403 | 1,247 | 1,108 |
Nplate Nplate Growth | 1,699 | 1,524 | 1,456 | 1,477 | 1,307 | 1,027 |
Aranesp Aranesp Growth | 1,325 | 1,389 | 1,342 | 1,362 | 1,421 | 1,480 |
BLINCYTO BLINCYTO Growth | 1,796 | 1,559 | 1,216 | 861 | 583 | 472 |
KRYSTEXXA KRYSTEXXA Growth | 1,509 | 1,340 | 1,185 | 272 | - | - |
Vectibix Vectibix Growth | 1,279 | 1,175 | 1,045 | 984 | 893 | 873 |
TEZSPIRE TEZSPIRE Growth | 1,841 | 1,478 | 972 | 567 | 170 | - |
Other Products Other Products Growth | 9,031 | 7,263 | 5,630 | 4,696 | 5,050 | 5,710 |
Other Other Growth | 1,898 | 1,603 | 1,398 | 1,280 | 1,522 | 1,682 |
Revenue (Total) Revenue (Total) Growth | 38,903 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,190 | 9,129 | 11,973 | 10,944 | 9,305 | 8,037 |
Total Debt Total Debt Growth | 54,007 | 55,435 | 60,879 | 65,423 | 39,640 | 33,979 |
Net Cash (Debt) Net Cash Growth | -40,817 | -46,306 | -48,906 | -54,479 | -30,335 | -25,942 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -75.00 | -85.44 | -90.40 | -101.26 | -56.07 | -45.27 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 12,035 | 9,958 | 11,490 | 8,471 | 9,721 | 9,261 |
Capital Expenditures CapEx Growth | -2,454 | -1,858 | -1,096 | -1,112 | -936 | -880 |
Free Cash Flow Free Cash Flow Growth | 9,581 | 8,100 | 10,394 | 7,359 | 8,785 | 8,381 |
Free Cash Flow Growth | -16.97% | -22.07% | 41.24% | -16.23% | 4.82% | -15.25% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.47% | 70.78% | 68.71% | 72.35% | 75.78% | 75.16% |
Operating Margin | 34.12% | 31.49% | 28.95% | 34.85% | 38.36% | 35.23% |
Pretax Margin | 28.41% | 24.42% | 13.79% | 27.86% | 27.91% | 25.79% |
Profit Margin | 24.14% | 20.98% | 12.24% | 23.83% | 24.89% | 22.68% |
FCF Margin | 24.63% | 22.04% | 31.10% | 26.11% | 33.37% | 32.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 10.080 | 9.520 | 9.000 | 8.520 | 7.760 | 7.040 |
Dividend Per Share Growth | 5.88% | 5.78% | 5.63% | 9.79% | 10.23% | 10.00% |
Dividend Yield | 2.19% | 2.91% | 3.45% | 2.96% | 2.96% | 3.10% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.68 | 22.86 | 34.26 | 22.95 | 21.39 | 21.50 |
Forward PE | 18.96 | 15.46 | 12.59 | 14.95 | 14.40 | 13.06 |
P/FCF Ratio | 25.99 | 21.76 | 13.48 | 20.95 | 15.95 | 15.12 |
PS Ratio | 6.40 | 4.80 | 4.19 | 5.47 | 5.32 | 4.88 |